Bangladesh's Beximo signs covid-19 deal with India's Serum Institute, what is it: Watch | Oneindia

Video Credit: Oneindia
Published on August 30, 2020 - Duration: 01:08s

Bangladesh's Beximo signs covid-19 deal with India's Serum Institute, what is it: Watch | Oneindia

As the race for a COVID-19 vaccine rages on, Bangladesh's leading pharma company Beximco has announced it will be investing in Adar Poonawalla's Serum India Limited for development of the vaccine.

The deal is designed to ensure that Bangladesh is among the first countries to receive an agreed quantity of this vaccine from Serum India Limited on a priority basis.

The investment will be treated as an advance for the vaccine.


You are here

Related videos from verified sources

Covid: Serum Institute begins human trials, 5 volunteers given first shot 02:01
Video credit: HT Digital Content - Published on August 26, 2020 

Second national sero-survey to be completed in September first week: ICMR 01:49
Video credit: ANI - Published on August 25, 2020 

Covid update: Serum Institute clarifies; SOPs for TV shoots; weekend lockdown 02:32
Video credit: HT Digital Content - Published on August 23, 2020 

You might like